• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,205.66 -574.76
(-1.13%)
Dow Jones
7,342.05 -19.48
(-0.26%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
432.1356994
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
40.17
114720.11
EPS(TTM)
Face Value()
Div & Yield %
35.35
2
0.92
 

EFC (I) consolidated net profit rises 58.91% in the June 2026 quarter
Jul 30,2026
Net profit of EFC (I) rose 58.91% to Rs 69.00 crore in the quarter ended June 2026 as against Rs 43.42 crore during the previous quarter ended June 2025. Sales rose 28.80% to Rs 282.88 crore in the quarter ended June 2026 as against Rs 219.62 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales282.88219.62 29
OPM %43.4746.52 -
PBDT124.0394.24 32
PBT101.3466.06 53
NP69.0043.42 59